Skip to main content
VCbacked
Log inGet Started

Zero Point Five Therapeutics

Potomac, United States

Zero Point Five Therapeutics develops drugs to treat soil-transmitted helminthiasis.

$4.3M raised
Apr 2025
Venture - Series Unknown
Health CarePharmaceuticalTherapeutics

Top Investors

Portfolia

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Zero Point Five Therapeutics

How much funding has Zero Point Five Therapeutics raised?
Zero Point Five Therapeutics has raised $4.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Who are Zero Point Five Therapeutics's investors?
Zero Point Five Therapeutics's investors include Portfolia.
Where is Zero Point Five Therapeutics headquartered?
Zero Point Five Therapeutics is headquartered in Potomac, United States.
What does Zero Point Five Therapeutics do?
Zero Point Five Therapeutics develops drugs to treat soil-transmitted helminthiasis.
What stage is Zero Point Five Therapeutics at?
Zero Point Five Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Zero Point Five Therapeutics — Funding & Investors." VCBacked, April 17, 2025, https://www.vcbacked.co/company/zero-point-five-therapeutics. Accessed June 19, 2026.
APA
VCBacked. (2025). Zero Point Five Therapeutics — Funding & Investors. Retrieved June 19, 2026, from https://www.vcbacked.co/company/zero-point-five-therapeutics
Wikipedia (cite web)
{{cite web |title=Zero Point Five Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/zero-point-five-therapeutics |website=VCBacked |access-date=June 19, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K